BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 21482675)

  • 21. Inhibition of Ovarian Epithelial Carcinoma Tumorigenesis and Progression by microRNA 106b Mediated through the RhoC Pathway.
    Chen S; Chen X; Xiu YL; Sun KX; Zhao Y
    PLoS One; 2015; 10(5):e0125714. PubMed ID: 25933027
    [TBL] [Abstract][Full Text] [Related]  

  • 22. nm23 gene polymorphisms are associated with survival of patients with epithelial ovarian cancer but not with susceptibility to disease.
    Li Y; Kang S; Qin JJ; Wang N; Zhou RM; Sun HY
    Gynecol Oncol; 2012 Sep; 126(3):455-9. PubMed ID: 22683585
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic polymorphisms in the Fas and FasL genes are associated with epithelial ovarian cancer risk and clinical outcomes.
    Li Y; Hao YL; Kang S; Zhou RM; Wang N; Qi BL
    Gynecol Oncol; 2013 Mar; 128(3):584-9. PubMed ID: 23234803
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of single nucleotide polymorphisms of the ERCC1 and MMS19 genes in predicting platinum-sensitivity, progression-free and overall survival in advanced epithelial ovarian cancer.
    Moxley KM; Benbrook DM; Queimado L; Zuna RE; Thompson D; McCumber M; Premkumar P; Thavathiru E; Hines L; Moore KN
    Gynecol Oncol; 2013 Aug; 130(2):377-82. PubMed ID: 23632208
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel miRNA genes deregulated by aberrant methylation in ovarian carcinoma are involved in metastasis.
    Loginov VI; Pronina IV; Burdennyy AM; Filippova EA; Kazubskaya TP; Kushlinsky DN; Utkin DO; Khodyrev DS; Kushlinskii NE; Dmitriev AA; Braga EA
    Gene; 2018 Jul; 662():28-36. PubMed ID: 29631007
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of serum miR-200a, miR-200b, and miR-200c as candidate biomarkers in epithelial ovarian cancer and their association with clinicopathological features.
    Zuberi M; Mir R; Das J; Ahmad I; Javid J; Yadav P; Masroor M; Ahmad S; Ray PC; Saxena A
    Clin Transl Oncol; 2015 Oct; 17(10):779-87. PubMed ID: 26063644
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum microRNA-92 expression in patients with ovarian epithelial carcinoma.
    Guo F; Tian J; Lin Y; Jin Y; Wang L; Cui M
    J Int Med Res; 2013 Oct; 41(5):1456-61. PubMed ID: 23963852
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A targeted genetic association study of epithelial ovarian cancer susceptibility.
    Earp M; Winham SJ; Larson N; Permuth JB; Sicotte H; Chien J; Anton-Culver H; Bandera EV; Berchuck A; Cook LS; Cramer D; Doherty JA; Goodman MT; Levine DA; Monteiro AN; Ness RB; Pearce CL; Rossing MA; Tworoger SS; Wentzensen N; Bisogna M; Brinton L; Brooks-Wilson A; Carney ME; Cunningham JM; Edwards RP; Fogarty ZC; Iversen ES; Kraft P; Larson MC; Le ND; Lin HY; Lissowska J; Modugno F; Moysich KB; Olson SH; Pike MC; Poole EM; Rider DN; Terry KL; Thompson PJ; van den Berg D; Vierkant RA; Vitonis AF; Wilkens LR; Wu AH; Yang HP; Ziogas A; Phelan CM; Schildkraut JM; Chen YA; Sellers TA; Fridley BL; Goode EL
    Oncotarget; 2016 Feb; 7(7):7381-9. PubMed ID: 26848776
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Let-7e sensitizes epithelial ovarian cancer to cisplatin through repressing DNA double strand break repair.
    Xiao M; Cai J; Cai L; Jia J; Xie L; Zhu Y; Huang B; Jin D; Wang Z
    J Ovarian Res; 2017 Apr; 10(1):24. PubMed ID: 28376831
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.
    Phelan CM; Kuchenbaecker KB; Tyrer JP; Kar SP; Lawrenson K; Winham SJ; Dennis J; Pirie A; Riggan MJ; Chornokur G; Earp MA; Lyra PC; Lee JM; Coetzee S; Beesley J; McGuffog L; Soucy P; Dicks E; Lee A; Barrowdale D; Lecarpentier J; Leslie G; Aalfs CM; Aben KKH; Adams M; Adlard J; Andrulis IL; Anton-Culver H; Antonenkova N; ; Aravantinos G; Arnold N; Arun BK; Arver B; Azzollini J; Balmaña J; Banerjee SN; Barjhoux L; Barkardottir RB; Bean Y; Beckmann MW; Beeghly-Fadiel A; Benitez J; Bermisheva M; Bernardini MQ; Birrer MJ; Bjorge L; Black A; Blankstein K; Blok MJ; Bodelon C; Bogdanova N; Bojesen A; Bonanni B; Borg Å; Bradbury AR; Brenton JD; Brewer C; Brinton L; Broberg P; Brooks-Wilson A; Bruinsma F; Brunet J; Buecher B; Butzow R; Buys SS; Caldes T; Caligo MA; Campbell I; Cannioto R; Carney ME; Cescon T; Chan SB; Chang-Claude J; Chanock S; Chen XQ; Chiew YE; Chiquette J; Chung WK; Claes KBM; Conner T; Cook LS; Cook J; Cramer DW; Cunningham JM; D'Aloisio AA; Daly MB; Damiola F; Damirovna SD; Dansonka-Mieszkowska A; Dao F; Davidson R; DeFazio A; Delnatte C; Doheny KF; Diez O; Ding YC; Doherty JA; Domchek SM; Dorfling CM; Dörk T; Dossus L; Duran M; Dürst M; Dworniczak B; Eccles D; Edwards T; Eeles R; Eilber U; Ejlertsen B; Ekici AB; Ellis S; Elvira M; ; Eng KH; Engel C; Evans DG; Fasching PA; Ferguson S; Ferrer SF; Flanagan JM; Fogarty ZC; Fortner RT; Fostira F; Foulkes WD; Fountzilas G; Fridley BL; Friebel TM; Friedman E; Frost D; Ganz PA; Garber J; García MJ; Garcia-Barberan V; Gehrig A; ; Gentry-Maharaj A; Gerdes AM; Giles GG; Glasspool R; Glendon G; Godwin AK; Goldgar DE; Goranova T; Gore M; Greene MH; Gronwald J; Gruber S; Hahnen E; Haiman CA; Håkansson N; Hamann U; Hansen TVO; Harrington PA; Harris HR; Hauke J; ; Hein A; Henderson A; Hildebrandt MAT; Hillemanns P; Hodgson S; Høgdall CK; Høgdall E; Hogervorst FBL; Holland H; Hooning MJ; Hosking K; Huang RY; Hulick PJ; Hung J; Hunter DJ; Huntsman DG; Huzarski T; Imyanitov EN; Isaacs C; Iversen ES; Izatt L; Izquierdo A; Jakubowska A; James P; Janavicius R; Jernetz M; Jensen A; Jensen UB; John EM; Johnatty S; Jones ME; Kannisto P; Karlan BY; Karnezis A; Kast K; ; Kennedy CJ; Khusnutdinova E; Kiemeney LA; Kiiski JI; Kim SW; Kjaer SK; Köbel M; Kopperud RK; Kruse TA; Kupryjanczyk J; Kwong A; Laitman Y; Lambrechts D; Larrañaga N; Larson MC; Lazaro C; Le ND; Le Marchand L; Lee JW; Lele SB; Leminen A; Leroux D; Lester J; Lesueur F; Levine DA; Liang D; Liebrich C; Lilyquist J; Lipworth L; Lissowska J; Lu KH; Lubinński J; Luccarini C; Lundvall L; Mai PL; Mendoza-Fandiño G; Manoukian S; Massuger LFAG; May T; Mazoyer S; McAlpine JN; McGuire V; McLaughlin JR; McNeish I; Meijers-Heijboer H; Meindl A; Menon U; Mensenkamp AR; Merritt MA; Milne RL; Mitchell G; Modugno F; Moes-Sosnowska J; Moffitt M; Montagna M; Moysich KB; Mulligan AM; Musinsky J; Nathanson KL; Nedergaard L; Ness RB; Neuhausen SL; Nevanlinna H; Niederacher D; Nussbaum RL; Odunsi K; Olah E; Olopade OI; Olsson H; Olswold C; O'Malley DM; Ong KR; Onland-Moret NC; ; Orr N; Orsulic S; Osorio A; Palli D; Papi L; Park-Simon TW; Paul J; Pearce CL; Pedersen IS; Peeters PHM; Peissel B; Peixoto A; Pejovic T; Pelttari LM; Permuth JB; Peterlongo P; Pezzani L; Pfeiler G; Phillips KA; Piedmonte M; Pike MC; Piskorz AM; Poblete SR; Pocza T; Poole EM; Poppe B; Porteous ME; Prieur F; Prokofyeva D; Pugh E; Pujana MA; Pujol P; Radice P; Rantala J; Rappaport-Fuerhauser C; Rennert G; Rhiem K; Rice P; Richardson A; Robson M; Rodriguez GC; Rodríguez-Antona C; Romm J; Rookus MA; Rossing MA; Rothstein JH; Rudolph A; Runnebaum IB; Salvesen HB; Sandler DP; Schoemaker MJ; Senter L; Setiawan VW; Severi G; Sharma P; Shelford T; Siddiqui N; Side LE; Sieh W; Singer CF; Sobol H; Song H; Southey MC; Spurdle AB; Stadler Z; Steinemann D; Stoppa-Lyonnet D; Sucheston-Campbell LE; Sukiennicki G; Sutphen R; Sutter C; Swerdlow AJ; Szabo CI; Szafron L; Tan YY; Taylor JA; Tea MK; Teixeira MR; Teo SH; Terry KL; Thompson PJ; Thomsen LCV; Thull DL; Tihomirova L; Tinker AV; Tischkowitz M; Tognazzo S; Toland AE; Tone A; Trabert B; Travis RC; Trichopoulou A; Tung N; Tworoger SS; van Altena AM; Van Den Berg D; van der Hout AH; van der Luijt RB; Van Heetvelde M; Van Nieuwenhuysen E; van Rensburg EJ; Vanderstichele A; Varon-Mateeva R; Vega A; Edwards DV; Vergote I; Vierkant RA; Vijai J; Vratimos A; Walker L; Walsh C; Wand D; Wang-Gohrke S; Wappenschmidt B; Webb PM; Weinberg CR; Weitzel JN; Wentzensen N; Whittemore AS; Wijnen JT; Wilkens LR; Wolk A; Woo M; Wu X; Wu AH; Yang H; Yannoukakos D; Ziogas A; Zorn KK; Narod SA; Easton DF; Amos CI; Schildkraut JM; Ramus SJ; Ottini L; Goodman MT; Park SK; Kelemen LE; Risch HA; Thomassen M; Offit K; Simard J; Schmutzler RK; Hazelett D; Monteiro AN; Couch FJ; Berchuck A; Chenevix-Trench G; Goode EL; Sellers TA; Gayther SA; Antoniou AC; Pharoah PDP
    Nat Genet; 2017 May; 49(5):680-691. PubMed ID: 28346442
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA let-7g acts as tumor suppressor and predictive biomarker for chemoresistance in human epithelial ovarian cancer.
    Biamonte F; Santamaria G; Sacco A; Perrone FM; Di Cello A; Battaglia AM; Salatino A; Di Vito A; Aversa I; Venturella R; Zullo F; Costanzo F
    Sci Rep; 2019 Apr; 9(1):5668. PubMed ID: 30952937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A functional variant in HOXA11-AS, a novel long non-coding RNA, inhibits the oncogenic phenotype of epithelial ovarian cancer.
    Richards EJ; Permuth-Wey J; Li Y; Chen YA; Coppola D; Reid BM; Lin HY; Teer JK; Berchuck A; Birrer MJ; Lawrenson K; Monteiro AN; Schildkraut JM; Goode EL; Gayther SA; Sellers TA; Cheng JQ
    Oncotarget; 2015 Oct; 6(33):34745-57. PubMed ID: 26430965
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA-150 predicts a favorable prognosis in patients with epithelial ovarian cancer, and inhibits cell invasion and metastasis by suppressing transcriptional repressor ZEB1.
    Jin M; Yang Z; Ye W; Xu H; Hua X
    PLoS One; 2014; 9(8):e103965. PubMed ID: 25090005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polymorphisms in the kinesin-like factor 1 B gene and risk of epithelial ovarian cancer in Eastern Chinese women.
    Shi TY; Jiang Z; Jiang R; Yin S; Wang MY; Yu KD; Shao ZM; Sun MH; Zang R; Wei Q
    Tumour Biol; 2015 Sep; 36(9):6919-27. PubMed ID: 25854172
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of six new susceptibility loci for invasive epithelial ovarian cancer.
    Kuchenbaecker KB; Ramus SJ; Tyrer J; Lee A; Shen HC; Beesley J; Lawrenson K; McGuffog L; Healey S; Lee JM; Spindler TJ; Lin YG; Pejovic T; Bean Y; Li Q; Coetzee S; Hazelett D; Miron A; Southey M; Terry MB; Goldgar DE; Buys SS; Janavicius R; Dorfling CM; van Rensburg EJ; Neuhausen SL; Ding YC; Hansen TV; Jønson L; Gerdes AM; Ejlertsen B; Barrowdale D; Dennis J; Benitez J; Osorio A; Garcia MJ; Komenaka I; Weitzel JN; Ganschow P; Peterlongo P; Bernard L; Viel A; Bonanni B; Peissel B; Manoukian S; Radice P; Papi L; Ottini L; Fostira F; Konstantopoulou I; Garber J; Frost D; Perkins J; Platte R; Ellis S; ; Godwin AK; Schmutzler RK; Meindl A; Engel C; Sutter C; Sinilnikova OM; ; Damiola F; Mazoyer S; Stoppa-Lyonnet D; Claes K; De Leeneer K; Kirk J; Rodriguez GC; Piedmonte M; O'Malley DM; de la Hoya M; Caldes T; Aittomäki K; Nevanlinna H; Collée JM; Rookus MA; Oosterwijk JC; ; Tihomirova L; Tung N; Hamann U; Isaccs C; Tischkowitz M; Imyanitov EN; Caligo MA; Campbell IG; Hogervorst FB; ; Olah E; Diez O; Blanco I; Brunet J; Lazaro C; Pujana MA; Jakubowska A; Gronwald J; Lubinski J; Sukiennicki G; Barkardottir RB; Plante M; Simard J; Soucy P; Montagna M; Tognazzo S; Teixeira MR; ; Pankratz VS; Wang X; Lindor N; Szabo CI; Kauff N; Vijai J; Aghajanian CA; Pfeiler G; Berger A; Singer CF; Tea MK; Phelan CM; Greene MH; Mai PL; Rennert G; Mulligan AM; Tchatchou S; Andrulis IL; Glendon G; Toland AE; Jensen UB; Kruse TA; Thomassen M; Bojesen A; Zidan J; Friedman E; Laitman Y; Soller M; Liljegren A; Arver B; Einbeigi Z; Stenmark-Askmalm M; Olopade OI; Nussbaum RL; Rebbeck TR; Nathanson KL; Domchek SM; Lu KH; Karlan BY; Walsh C; Lester J; ; ; Hein A; Ekici AB; Beckmann MW; Fasching PA; Lambrechts D; Van Nieuwenhuysen E; Vergote I; Lambrechts S; Dicks E; Doherty JA; Wicklund KG; Rossing MA; Rudolph A; Chang-Claude J; Wang-Gohrke S; Eilber U; Moysich KB; Odunsi K; Sucheston L; Lele S; Wilkens LR; Goodman MT; Thompson PJ; Shvetsov YB; Runnebaum IB; Dürst M; Hillemanns P; Dörk T; Antonenkova N; Bogdanova N; Leminen A; Pelttari LM; Butzow R; Modugno F; Kelley JL; Edwards RP; Ness RB; du Bois A; Heitz F; Schwaab I; Harter P; Matsuo K; Hosono S; Orsulic S; Jensen A; Kjaer SK; Hogdall E; Hasmad HN; Azmi MA; Teo SH; Woo YL; Fridley BL; Goode EL; Cunningham JM; Vierkant RA; Bruinsma F; Giles GG; Liang D; Hildebrandt MA; Wu X; Levine DA; Bisogna M; Berchuck A; Iversen ES; Schildkraut JM; Concannon P; Weber RP; Cramer DW; Terry KL; Poole EM; Tworoger SS; Bandera EV; Orlow I; Olson SH; Krakstad C; Salvesen HB; Tangen IL; Bjorge L; van Altena AM; Aben KK; Kiemeney LA; Massuger LF; Kellar M; Brooks-Wilson A; Kelemen LE; Cook LS; Le ND; Cybulski C; Yang H; Lissowska J; Brinton LA; Wentzensen N; Hogdall C; Lundvall L; Nedergaard L; Baker H; Song H; Eccles D; McNeish I; Paul J; Carty K; Siddiqui N; Glasspool R; Whittemore AS; Rothstein JH; McGuire V; Sieh W; Ji BT; Zheng W; Shu XO; Gao YT; Rosen B; Risch HA; McLaughlin JR; Narod SA; Monteiro AN; Chen A; Lin HY; Permuth-Wey J; Sellers TA; Tsai YY; Chen Z; Ziogas A; Anton-Culver H; Gentry-Maharaj A; Menon U; Harrington P; Lee AW; Wu AH; Pearce CL; Coetzee G; Pike MC; Dansonka-Mieszkowska A; Timorek A; Rzepecka IK; Kupryjanczyk J; Freedman M; Noushmehr H; Easton DF; Offit K; Couch FJ; Gayther S; Pharoah PP; Antoniou AC; Chenevix-Trench G;
    Nat Genet; 2015 Feb; 47(2):164-71. PubMed ID: 25581431
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-127-3p acts as a tumor suppressor in epithelial ovarian cancer by regulating the BAG5 gene.
    Bi L; Yang Q; Yuan J; Miao Q; Duan L; Li F; Wang S
    Oncol Rep; 2016 Nov; 36(5):2563-2570. PubMed ID: 27571744
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNA hypomethylation-mediated activation of Cancer/Testis Antigen 45 (CT45) genes is associated with disease progression and reduced survival in epithelial ovarian cancer.
    Zhang W; Barger CJ; Link PA; Mhawech-Fauceglia P; Miller A; Akers SN; Odunsi K; Karpf AR
    Epigenetics; 2015; 10(8):736-48. PubMed ID: 26098711
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA-130b functions as a tumor suppressor by regulating RUNX3 in epithelial ovarian cancer.
    Paudel D; Zhou W; Ouyang Y; Dong S; Huang Q; Giri R; Wang J; Tong X
    Gene; 2016 Jul; 586(1):48-55. PubMed ID: 27048832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between PIWIL1 gene polymorphisms and epithelial ovarian cancer susceptibility among southern Chinese woman: a three-center case-control study.
    Liu S; Yan Y; Cui Z; Feng H; Zhong F; Liu Z; Li Y; Ou X; Li W
    BMC Cancer; 2023 Nov; 23(1):1149. PubMed ID: 38012622
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Haptoglobin phenotype and epithelial ovarian cancer.
    Mandato VD; Magnani E; Abrate M; Casali B; Nicoli D; Farnetti E; Formisano D; Pirillo D; Ciarlini G; De Iaco P; Strada I; Zamagni C; La Sala GB
    Anticancer Res; 2012 Oct; 32(10):4353-8. PubMed ID: 23060558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.